179 related articles for article (PubMed ID: 23868000)
1. Expression pattern of tumour-associated antigens in hepatocellular carcinoma: association with immune infiltration and disease progression.
Liang J; Ding T; Guo ZW; Yu XJ; Hu YZ; Zheng L; Xu J
Br J Cancer; 2013 Aug; 109(4):1031-9. PubMed ID: 23868000
[TBL] [Abstract][Full Text] [Related]
2. CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.
Li L; Yan J; Xu J; Liu CQ; Zhen ZJ; Chen HW; Ji Y; Wu ZP; Hu JY; Zheng L; Lau WY
PLoS One; 2014; 9(10):e110064. PubMed ID: 25303284
[TBL] [Abstract][Full Text] [Related]
3. Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages.
Zang C; Zhao Y; Qin L; Liu G; Sun J; Li K; Zhao Y; Sheng S; Zhang H; He N; Zhao P; Wang Q; Li X; Peng Y; Dong T; Zhang Y
BMC Cancer; 2021 Sep; 21(1):1007. PubMed ID: 34496797
[TBL] [Abstract][Full Text] [Related]
4. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma.
Chew V; Chen J; Lee D; Loh E; Lee J; Lim KH; Weber A; Slankamenac K; Poon RT; Yang H; Ooi LL; Toh HC; Heikenwalder M; Ng IO; Nardin A; Abastado JP
Gut; 2012 Mar; 61(3):427-38. PubMed ID: 21930732
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
Mizukoshi E; Nakamoto Y; Arai K; Yamashita T; Sakai A; Sakai Y; Kagaya T; Yamashita T; Honda M; Kaneko S
Hepatology; 2011 Apr; 53(4):1206-16. PubMed ID: 21480325
[TBL] [Abstract][Full Text] [Related]
6. Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma.
Bricard G; Bouzourene H; Martinet O; Rimoldi D; Halkic N; Gillet M; Chaubert P; Macdonald HR; Romero P; Cerottini JC; Speiser DE
J Immunol; 2005 Feb; 174(3):1709-16. PubMed ID: 15661935
[TBL] [Abstract][Full Text] [Related]
7. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
[TBL] [Abstract][Full Text] [Related]
8. Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area.
Sideras K; Bots SJ; Biermann K; Sprengers D; Polak WG; IJzermans JN; de Man RA; Pan Q; Sleijfer S; Bruno MJ; Kwekkeboom J
Br J Cancer; 2015 Jun; 112(12):1911-20. PubMed ID: 26057582
[TBL] [Abstract][Full Text] [Related]
9. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
10. VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.
Zhang M; Pang HJ; Zhao W; Li YF; Yan LX; Dong ZY; He XF
BMC Cancer; 2018 May; 18(1):511. PubMed ID: 29720116
[TBL] [Abstract][Full Text] [Related]
11. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
[TBL] [Abstract][Full Text] [Related]
12. EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
Shu Y; He L; Gao M; Xiao F; Yang J; Wang S; Wei H; Zhang F; Wei H
Front Immunol; 2021; 12():780509. PubMed ID: 35069551
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic significance of natural killer cell infiltration in hepatocellular carcinoma].
Zhu LY; Zhou J; Liu YZ; Pan WD
Ai Zheng; 2009 Nov; 28(11):1198-202. PubMed ID: 19895742
[TBL] [Abstract][Full Text] [Related]
14. Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection.
Fu SJ; Qi CY; Xiao WK; Li SQ; Peng BG; Liang LJ
Surgery; 2013 Sep; 154(3):536-44. PubMed ID: 23601901
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.
Huang Y; Wang FM; Wang T; Wang YJ; Zhu ZY; Gao YT; Du Z
Digestion; 2012; 86(4):329-37. PubMed ID: 23207161
[TBL] [Abstract][Full Text] [Related]
16. Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation.
Itoh S; Yoshizumi T; Yugawa K; Imai D; Yoshiya S; Takeishi K; Toshima T; Harada N; Ikegami T; Soejima Y; Kohashi K; Oda Y; Mori M
Hepatology; 2020 Dec; 72(6):1987-1999. PubMed ID: 32112577
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma.
Ohno A; Yorita K; Haruyama Y; Kondo K; Kato A; Ohtomo T; Kawaguchi M; Marutuska K; Chijiiwa K; Kataoka H
Liver Int; 2014 Jul; 34(6):942-52. PubMed ID: 24433439
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection.
Chen KJ; Zhou L; Xie HY; Ahmed TE; Feng XW; Zheng SS
Med Oncol; 2012 Sep; 29(3):1817-26. PubMed ID: 21678026
[TBL] [Abstract][Full Text] [Related]
19. Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study.
Okada R; Otsuka Y; Wakabayashi T; Shinoda M; Aoki T; Murakami M; Arizumi S; Yamamoto M; Aramaki O; Takayama T; Wakiyama S; Yanaga K; Amikura K; Kaneko H; Shimada H
Int J Cancer; 2020 Nov; 147(9):2578-2586. PubMed ID: 32574375
[TBL] [Abstract][Full Text] [Related]
20. Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma.
Hiroishi K; Eguchi J; Baba T; Shimazaki T; Ishii S; Hiraide A; Sakaki M; Doi H; Uozumi S; Omori R; Matsumura T; Yanagawa T; Ito T; Imawari M
J Gastroenterol; 2010 Apr; 45(4):451-8. PubMed ID: 19936602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]